Skip to main content
Top
Published in: Cancer Causes & Control 2/2016

01-02-2016 | Original paper

Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort

Authors: Ora Paltiel, Salman M. Tajuddin, Yelena Polanker, Shoshanah Yazdgerdi, Orly Manor, Yechiel Friedlander, Susan Harlap, Ronit Calderon-Margalit

Published in: Cancer Causes & Control | Issue 2/2016

Login to get access

Abstract

Objectives

Grand multiparity is associated with reduced mortality from reproductive cancers. We aimed to separate the components of mortality, by measuring incidence of and survival after reproductive cancer onset in grand multiparous compared to other parous women.

Study design

We linked data from the population-based Jerusalem Perinatal Study Cohort, which included women aged 13–55 who delivered 1964–1976, with Israel’s National Cancer Registry. We compared breast and gynecologic cancer risk and all-cause survival following a cancer diagnosis, among grand multiparae (GMPs = parity 5+, n = 8,246) versus women with parity 1–4 (n = 19,703), adjusting for reproductive and demographic variables.

Results

Grand multiparae were at significantly lower risk of breast cancer than others (adjusted hazard ratio (HRadj) = 0.62, 95 % confidence interval (CI) 0.54–0.71), after controlling for age at first birth, education, and other covariates. This reduction was greater among GMPs whose first birth occurred after age 30 (p-interaction = 0.0001) and for cancer occurring before age 50 years (p = 0.002). In contrast, GMPs were at greater risk of death than women with parity <5, following a breast cancer diagnosis (HRadj = 1.69, CI 1.39–2.1). Ovarian, uterine, and cervical cancer incidence did not differ between the groups, but survival was reduced for GMPs with uterine cancer (HRadj = 2.48, CI 1.22–5.03).

Conclusion

Reduced reproductive cancer mortality reported among GMPs masks two opposing phenomena: decreased breast cancer risk and poorer survival after breast and uterine cancers. The latter unfavorable outcome suggests that tumors in GMPs may be particularly aggressive, having perhaps escaped protective mechanisms conferred by parity. This finding calls for heightened clinical attention in this group.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bai J, Wong FWS, Bauman A, Mohsin M (2002) Parity and pregnancy outcomes. Am J Obstet Gynecol 186(2):274–278PubMedCrossRef Bai J, Wong FWS, Bauman A, Mohsin M (2002) Parity and pregnancy outcomes. Am J Obstet Gynecol 186(2):274–278PubMedCrossRef
2.
go back to reference Omoloe-Ohonsi A, Ashimi AO (2011) Grand multiparity: obstetric performance in Aminu Kano teaching hospital, Kano, Nigeria. Niger J Clin Pract 14(1):6–9CrossRef Omoloe-Ohonsi A, Ashimi AO (2011) Grand multiparity: obstetric performance in Aminu Kano teaching hospital, Kano, Nigeria. Niger J Clin Pract 14(1):6–9CrossRef
3.
go back to reference Rizk DEE, Khalfan M, Ezimokhai M (2001) Obstetric outcome in grand multipara in the United Arab Emirates: a case control study. Arch Gynecol Obstet 264(4):194–198PubMedCrossRef Rizk DEE, Khalfan M, Ezimokhai M (2001) Obstetric outcome in grand multipara in the United Arab Emirates: a case control study. Arch Gynecol Obstet 264(4):194–198PubMedCrossRef
4.
go back to reference Simmons D, Shaw J, McKenzie A, Eaton S, Cameron AJ, Zimmet P (2006) Is grand multiparity associated with an increased risk of dysglycaemia? Diabetologia 49(7):1522–1527PubMedCrossRef Simmons D, Shaw J, McKenzie A, Eaton S, Cameron AJ, Zimmet P (2006) Is grand multiparity associated with an increased risk of dysglycaemia? Diabetologia 49(7):1522–1527PubMedCrossRef
5.
6.
go back to reference Schechter Y, Levy A, Wiznitzer A, Zlotnik A, Sheiner E (2010) Obstetric complications in grand and great grand multiparous women. J Matern-Fet Neonatal Med 23(10):1211–1217CrossRef Schechter Y, Levy A, Wiznitzer A, Zlotnik A, Sheiner E (2010) Obstetric complications in grand and great grand multiparous women. J Matern-Fet Neonatal Med 23(10):1211–1217CrossRef
7.
go back to reference Aliyu MH, Jolly PE, Ehiri JE, Salihu HM (2005) High parity and adverse birth outcomes: exploring the maze. Birth 32(1):45–59PubMedCrossRef Aliyu MH, Jolly PE, Ehiri JE, Salihu HM (2005) High parity and adverse birth outcomes: exploring the maze. Birth 32(1):45–59PubMedCrossRef
8.
go back to reference Rortveit G, Hannestad YS, Dalveit AK, Hunskaar S (2001) Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study. Obstet Gynecol 98(6):1004–1010PubMedCrossRef Rortveit G, Hannestad YS, Dalveit AK, Hunskaar S (2001) Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study. Obstet Gynecol 98(6):1004–1010PubMedCrossRef
9.
go back to reference Jacobsen BK, Knutsen SF, Oda K, Fraser GE (2011) Parity and total, ischemic heart disease and stroke mortality. The Adventist health study, 1976–1988. Eur J Epidemiol 26(9):711–718PubMedPubMedCentralCrossRef Jacobsen BK, Knutsen SF, Oda K, Fraser GE (2011) Parity and total, ischemic heart disease and stroke mortality. The Adventist health study, 1976–1988. Eur J Epidemiol 26(9):711–718PubMedPubMedCentralCrossRef
10.
go back to reference Hinkula M, Kauppila A, Nayha S, Pukkala E (2006) Cause-specific mortality of grand multiparous women in Finland. Am J Epidemiol 163(4):367–373PubMedCrossRef Hinkula M, Kauppila A, Nayha S, Pukkala E (2006) Cause-specific mortality of grand multiparous women in Finland. Am J Epidemiol 163(4):367–373PubMedCrossRef
11.
go back to reference Koski-Rahikkala H, Pouta A, Pietilainen K, Hartikainen A-L (2006) Does parity affect mortality among parous women? J Epidemiol Community Health 60(11):968–973PubMedPubMedCentralCrossRef Koski-Rahikkala H, Pouta A, Pietilainen K, Hartikainen A-L (2006) Does parity affect mortality among parous women? J Epidemiol Community Health 60(11):968–973PubMedPubMedCentralCrossRef
12.
go back to reference Dior U, Hochner H, Friedlander Y et al (2013) Association between number of children and mortality of mothers: results of a 37-year follow-up study. Ann Epidemiol 23(1):13–18PubMedPubMedCentralCrossRef Dior U, Hochner H, Friedlander Y et al (2013) Association between number of children and mortality of mothers: results of a 37-year follow-up study. Ann Epidemiol 23(1):13–18PubMedPubMedCentralCrossRef
13.
go back to reference Chan TF, Wu CH, Changchien CC, Yang CY (2011) Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan. Aust NZ J Obstet Gynaecol 51(6):548–552CrossRef Chan TF, Wu CH, Changchien CC, Yang CY (2011) Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan. Aust NZ J Obstet Gynaecol 51(6):548–552CrossRef
14.
go back to reference Strand BH, Tverdal A, Claussen B, Zahl P-H (2005) Is birth history the key to highly educated women’s higher breast cancer mortality? A follow-up study of 500,000 women aged 35–54. Int J Cancer 117(6):1002–1006PubMedCrossRef Strand BH, Tverdal A, Claussen B, Zahl P-H (2005) Is birth history the key to highly educated women’s higher breast cancer mortality? A follow-up study of 500,000 women aged 35–54. Int J Cancer 117(6):1002–1006PubMedCrossRef
15.
go back to reference Jaffe DH, Eisenbach Z, Manor O (2011) The effect of parity on cause-specific mortality among married men and women. Matern Child Health J 15(3):376–385PubMedCrossRef Jaffe DH, Eisenbach Z, Manor O (2011) The effect of parity on cause-specific mortality among married men and women. Matern Child Health J 15(3):376–385PubMedCrossRef
17.
go back to reference Lenora J, Lekamwasam S, Karlsson MK (2009) Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Women’s Health 9:19PubMedPubMedCentralCrossRef Lenora J, Lekamwasam S, Karlsson MK (2009) Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Women’s Health 9:19PubMedPubMedCentralCrossRef
19.
go back to reference Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13(4):299–305PubMedCrossRef Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13(4):299–305PubMedCrossRef
20.
go back to reference Albrektsen G, Heuch I, Kvale G (1995) The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 72(2):480–484PubMedPubMedCentralCrossRef Albrektsen G, Heuch I, Kvale G (1995) The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 72(2):480–484PubMedPubMedCentralCrossRef
21.
go back to reference MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43(2):209–221PubMedPubMedCentral MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43(2):209–221PubMedPubMedCentral
24.
go back to reference Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461–1484PubMedCrossRef Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461–1484PubMedCrossRef
25.
go back to reference Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207–225PubMedCrossRef Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207–225PubMedCrossRef
27.
go back to reference Harlap S, Davies AM, Deutsch L et al (2007) The Jerusalem Perinatal Study Cohort, 1964–2005: methods and a review of the main results. Paediatr Perinat Epidemiol 21(3):256–273PubMedPubMedCentralCrossRef Harlap S, Davies AM, Deutsch L et al (2007) The Jerusalem Perinatal Study Cohort, 1964–2005: methods and a review of the main results. Paediatr Perinat Epidemiol 21(3):256–273PubMedPubMedCentralCrossRef
28.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2000) Cancer incidence in five continents. IARC Press (IARC scientific publications no. 155), Lyon Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2000) Cancer incidence in five continents. IARC Press (IARC scientific publications no. 155), Lyon
29.
go back to reference Fishler Y, Chetrit A (1997) First nationwide Cancer Registry data quality control survey in Israel: Israel Center for Disease Control, cancer program area. J Regist Manage 24(2):50–54 Fishler Y, Chetrit A (1997) First nationwide Cancer Registry data quality control survey in Israel: Israel Center for Disease Control, cancer program area. J Regist Manage 24(2):50–54
31.
go back to reference Lane-Claypon JE (1926) A further report on cancer of the breast with special references to its associated antecedent conditions. Reports on public health and medical subjects No. 32. Ministry of health London: Published by his majesty’s stationary office Lane-Claypon JE (1926) A further report on cancer of the breast with special references to its associated antecedent conditions. Reports on public health and medical subjects No. 32. Ministry of health London: Published by his majesty’s stationary office
32.
go back to reference Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 12(6):491–500PubMedCrossRef Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 12(6):491–500PubMedCrossRef
33.
go back to reference Russo IH, Russo J (2011) Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16(3):221–233PubMedCrossRef Russo IH, Russo J (2011) Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16(3):221–233PubMedCrossRef
34.
go back to reference Britt K, Ashworth A, Smalley M (2007) Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14(4):907–933PubMedCrossRef Britt K, Ashworth A, Smalley M (2007) Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14(4):907–933PubMedCrossRef
35.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187–195CrossRef Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187–195CrossRef
36.
go back to reference Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2002) Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer 98(6):912–915PubMedCrossRef Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2002) Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer 98(6):912–915PubMedCrossRef
37.
go back to reference Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2006) Incidence of ovarian cancer of grand multiparous women—a population-based study in Finland. Gynecol Oncol 103(1):207–211PubMedCrossRef Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2006) Incidence of ovarian cancer of grand multiparous women—a population-based study in Finland. Gynecol Oncol 103(1):207–211PubMedCrossRef
38.
go back to reference Hinkula M, Pukkala E, Kyyronen P et al (2004) A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Brit J Cancer 90(5):1025–1029PubMedPubMedCentralCrossRef Hinkula M, Pukkala E, Kyyronen P et al (2004) A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Brit J Cancer 90(5):1025–1029PubMedPubMedCentralCrossRef
39.
go back to reference Dossus L, Allen N, Kaaks R et al (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127(2):442–451PubMed Dossus L, Allen N, Kaaks R et al (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127(2):442–451PubMed
40.
go back to reference Haidopoulos D, Simou M, Akrivos N, Rodolakis A, Vlachos G, Fotiou S et al (2010) Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand 89(10):1326–1330PubMedCrossRef Haidopoulos D, Simou M, Akrivos N, Rodolakis A, Vlachos G, Fotiou S et al (2010) Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand 89(10):1326–1330PubMedCrossRef
41.
go back to reference Salvesen HB, Akslen LA, Albreksten G, Iversen OE (1998) Poorer survival of nulliparous women with endometrial carcinoma. Cancer 82(7):1328–1333PubMedCrossRef Salvesen HB, Akslen LA, Albreksten G, Iversen OE (1998) Poorer survival of nulliparous women with endometrial carcinoma. Cancer 82(7):1328–1333PubMedCrossRef
42.
go back to reference Albreksten G, Heuch I, Wik E, Salvesen HB (2009) Parity and time interval since childbirth influence survival in endometrial cancer patients. Int J Gynecol Cancer 19(4):665–669CrossRef Albreksten G, Heuch I, Wik E, Salvesen HB (2009) Parity and time interval since childbirth influence survival in endometrial cancer patients. Int J Gynecol Cancer 19(4):665–669CrossRef
43.
go back to reference Albreksten G, Heuch I, Wik E, Salvesen HB (2009) Prognostic impact of parity in 493 uterine sarcoma patients. Int J Gynecol Cancer 19(6):1062–1067CrossRef Albreksten G, Heuch I, Wik E, Salvesen HB (2009) Prognostic impact of parity in 493 uterine sarcoma patients. Int J Gynecol Cancer 19(6):1062–1067CrossRef
44.
go back to reference Hachisuga T, Fukuda K, Hirakawa T, Kawarabayashi T (2001) The effect of nulliparity on survival in endometrial cancer at different ages. Gynecol Oncol 82(1):122–126PubMedCrossRef Hachisuga T, Fukuda K, Hirakawa T, Kawarabayashi T (2001) The effect of nulliparity on survival in endometrial cancer at different ages. Gynecol Oncol 82(1):122–126PubMedCrossRef
45.
go back to reference Marth C, Windbichler G, Petru E et al (1997) Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 64(1):121–125PubMedCrossRef Marth C, Windbichler G, Petru E et al (1997) Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 64(1):121–125PubMedCrossRef
46.
go back to reference Barnett GC, Shah M, Redman K, Easton DF, Ponder BAJ, Pharoah PDP (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316PubMedCrossRef Barnett GC, Shah M, Redman K, Easton DF, Ponder BAJ, Pharoah PDP (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316PubMedCrossRef
47.
go back to reference Butt S, Borgquist S, Garne JP et al (2009) Parity in relation to survival following breast cancer. Eur J Surg Oncol 35(7):702–708PubMedCrossRef Butt S, Borgquist S, Garne JP et al (2009) Parity in relation to survival following breast cancer. Eur J Surg Oncol 35(7):702–708PubMedCrossRef
48.
go back to reference Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A (2011) Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat 130(3):975–980PubMedCrossRef Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A (2011) Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat 130(3):975–980PubMedCrossRef
49.
go back to reference Kadi M, Wark PA, Gunter MJ, Riboli E (2012) Parity and mortality from causes other than breast cancer in breast cancer patients. Breast Cancer Res Treat 131(3):1077–1081PubMedCrossRef Kadi M, Wark PA, Gunter MJ, Riboli E (2012) Parity and mortality from causes other than breast cancer in breast cancer patients. Breast Cancer Res Treat 131(3):1077–1081PubMedCrossRef
50.
go back to reference Trivers KF, Gammon MD, Abrahamson PE et al (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103(1):93–102PubMedCrossRef Trivers KF, Gammon MD, Abrahamson PE et al (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103(1):93–102PubMedCrossRef
51.
go back to reference Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA (2010) Risk factors for ductal and lobular breast cancer: results from the nurses’ health study. Breast Cancer Res 12(6):R106PubMedPubMedCentralCrossRef Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA (2010) Risk factors for ductal and lobular breast cancer: results from the nurses’ health study. Breast Cancer Res 12(6):R106PubMedPubMedCentralCrossRef
52.
go back to reference Albreksten G, Heuch I, Thoresen S (2010) Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer 10:226CrossRef Albreksten G, Heuch I, Thoresen S (2010) Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer 10:226CrossRef
53.
go back to reference Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L (2011) Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 20(9):1883–1891PubMedPubMedCentralCrossRef Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L (2011) Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 20(9):1883–1891PubMedPubMedCentralCrossRef
54.
go back to reference Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103(3):250–263PubMedPubMedCentralCrossRef Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103(3):250–263PubMedPubMedCentralCrossRef
55.
go back to reference Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D et al (2011) Triple-negative breast cancer in Hispanic patients. Cancer 117(16):3658–3669PubMedCrossRef Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D et al (2011) Triple-negative breast cancer in Hispanic patients. Cancer 117(16):3658–3669PubMedCrossRef
56.
go back to reference Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation of triple-negative breast cancer. J Natl Cancer Inst 103(6):470–477PubMedPubMedCentralCrossRef Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation of triple-negative breast cancer. J Natl Cancer Inst 103(6):470–477PubMedPubMedCentralCrossRef
57.
go back to reference Curigliano G, Godlhirsch A (2011) The triple-negative subtype: new ideas for the poorest prognosis breast cancer. J Natl Cancer Inst Monogr 43:108–110CrossRef Curigliano G, Godlhirsch A (2011) The triple-negative subtype: new ideas for the poorest prognosis breast cancer. J Natl Cancer Inst Monogr 43:108–110CrossRef
58.
go back to reference Metzger-Filho O, Sun Z, Viale G et al (2013) Patterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 31(25):3083–3090PubMedPubMedCentralCrossRef Metzger-Filho O, Sun Z, Viale G et al (2013) Patterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 31(25):3083–3090PubMedPubMedCentralCrossRef
59.
go back to reference Alsaker MDK, Opdahl S, Romundstad PR, Vatten LJ (2013) Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway. Int J Cancer 132(1):174–181PubMedCrossRef Alsaker MDK, Opdahl S, Romundstad PR, Vatten LJ (2013) Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway. Int J Cancer 132(1):174–181PubMedCrossRef
60.
go back to reference Zhao W, Grubbs CJ, Myers RK, Nilsen-Hamilton M (2010) Parity is associated with an expanded macrophage population in the mammary gland. Int J Oncol 37(5):1195–1202PubMed Zhao W, Grubbs CJ, Myers RK, Nilsen-Hamilton M (2010) Parity is associated with an expanded macrophage population in the mammary gland. Int J Oncol 37(5):1195–1202PubMed
61.
go back to reference Asztalos S, Gann PH, Hayes MK et al (2010) Gene expression patterns in the human breast after pregnancy. Cancer Prev Res 3(3):301–311CrossRef Asztalos S, Gann PH, Hayes MK et al (2010) Gene expression patterns in the human breast after pregnancy. Cancer Prev Res 3(3):301–311CrossRef
62.
go back to reference Ever-Hadani P, Seidman DS, Manor O, Harlap S (1994) Breast feeding in Israel: maternal factors associated with choice and duration. J Epidemiol Community Health 48(3):281–285PubMedPubMedCentralCrossRef Ever-Hadani P, Seidman DS, Manor O, Harlap S (1994) Breast feeding in Israel: maternal factors associated with choice and duration. J Epidemiol Community Health 48(3):281–285PubMedPubMedCentralCrossRef
63.
go back to reference Birenbaum-Carmeli D (2008) Your faith or mine: a pregnancy spacing intervention in an ultra-orthodox Jewish community in Israel. Reprod Health Matters 16(32):185–191PubMedCrossRef Birenbaum-Carmeli D (2008) Your faith or mine: a pregnancy spacing intervention in an ultra-orthodox Jewish community in Israel. Reprod Health Matters 16(32):185–191PubMedCrossRef
64.
go back to reference Baron-Epel D (2010) Attitudes and beliefs associated with mammography in a multiethnic population in Israel. Health Educ Behav 37(7):227–242PubMedCrossRef Baron-Epel D (2010) Attitudes and beliefs associated with mammography in a multiethnic population in Israel. Health Educ Behav 37(7):227–242PubMedCrossRef
65.
go back to reference Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408PubMedCrossRef Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408PubMedCrossRef
66.
go back to reference Oddoux C, Struewing JP, Clayton CM et al (1996) The carrier frequency of the BRCA2 6174 delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14(2):188–190PubMedCrossRef Oddoux C, Struewing JP, Clayton CM et al (1996) The carrier frequency of the BRCA2 6174 delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14(2):188–190PubMedCrossRef
67.
go back to reference Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2):185–187PubMedCrossRef Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2):185–187PubMedCrossRef
68.
go back to reference Brinton LA, Sakoda LC, Sherman ME et al (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 14(12):2929–2935PubMedCrossRef Brinton LA, Sakoda LC, Sherman ME et al (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 14(12):2929–2935PubMedCrossRef
Metadata
Title
Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort
Authors
Ora Paltiel
Salman M. Tajuddin
Yelena Polanker
Shoshanah Yazdgerdi
Orly Manor
Yechiel Friedlander
Susan Harlap
Ronit Calderon-Margalit
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0701-6

Other articles of this Issue 2/2016

Cancer Causes & Control 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine